ATRA - Atara Biotherapeutics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 51.52B
Enterprise Value 31.18B
Trailing P/E N/A
Forward P/E 1-6.82
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)3.36
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6-7.33

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2017
Most Recent Quarter (mrq)Jun 30, 2018

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-27.57%
Return on Equity (ttm)-47.13%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -160.93M
Net Income Avi to Common (ttm)-158.74M
Diluted EPS (ttm)-4.37
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)417.02M
Total Cash Per Share (mrq)9.2
Total Debt (mrq)10.3M
Total Debt/Equity (mrq)2.28
Current Ratio (mrq)15.61
Book Value Per Share (mrq)9.98

Cash Flow Statement

Operating Cash Flow (ttm)-119.42M
Levered Free Cash Flow (ttm)-102.72M

Trading Information

Stock Price History

Beta (3Y Monthly) 3.88
52-Week Change 3139.52%
S&P500 52-Week Change 37.91%
52 Week High 354.45
52 Week Low 312.65
50-Day Moving Average 339.32
200-Day Moving Average 340.80

Share Statistics

Avg Vol (3 month) 3565.37k
Avg Vol (10 day) 3347.48k
Shares Outstanding 545.34M
Float 28.77M
% Held by Insiders 110.14%
% Held by Institutions 1108.65%
Shares Short (Sep 28, 2018) 46.41M
Short Ratio (Sep 28, 2018) 49.01
Short % of Float (Sep 28, 2018) 423.09%
Short % of Shares Outstanding (Sep 28, 2018) 414.15%
Shares Short (prior month Aug 31, 2018) 46.19M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A